EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinical Implications of the C-Reactive Protein–Albumin Ratio as a Prognostic Marker in Terminally Ill Patients with Cancer

Koji Amano iD, Satomi Okamura, Tomofumi Miura iD, Vickie E Baracos, Naoharu Mori iD, Tatsuma Sakaguchi, Yu Uneno, Hiroto Ishiki, Yusuke Hiratsuka iD, Naosuke Yokomichi iD, Jun Hamano iD, Mika Baba und 2 weitere

Journal of Palliative Medicine · 2025

DOI: 10.1089/jpm.2024.0471 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Palliative Medicine, 2025. Verfasst von Koji Amano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Supportive and Palliative Care, Osaka International Cancer Institute, Osaka, Japan. Hauptthemen laut MEDLINE: C-Reactive Protein, Neoplasms, Terminally Ill, Palliative Care. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Few studies investigated the clinical implications of C-reactive protein-albumin ratio (CAR) in palliative care.

Objectives

To determine the association of CAR with overall survival among terminally ill patients with cance.

Design

Datasets were obtained through two multicenter prospective cohort studies. Setting/Subjects: Patients newly referred to palliative care.

Measurements

Physicians recorded measures at the baseline. Patients were followed up to their death or observed for 6 months. The patients in cohort 2 were divided using the CAR cutoffs detected using a piecewise linear hazards model in cohort 1. We performed time-to-event analyses using the Kaplan-Meier method and log-rank tests and univariate and multivariate Cox regression analyses for patients in cohort 2.

Results

A total of 1554 patients in cohort 1 and 1517 patients in cohort 2 were eligible. The cutoffs were 0.1, 1.2, and 6.4. The patients in cohort 2 were divided into four categories (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinNeoplasmsTerminally IllPalliative CareSerum AlbuminHumansMaleFemaleAgedMiddle AgedProspective StudiesPrognosisBiomarkersAged, 80 and overProportional Hazards ModelsAdult

Stichwörter der Autor:innen

C-reactive proteinalbumincachexiacancerprognosis

Substanzen

C-Reactive ProteinSerum AlbuminBiomarkers

Autor:innen und Institutionen

  • Department of Supportive and Palliative Care, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Medical Innovation, Osaka University Hospital, Osaka, Japan.
  • Department of Palliative Medicine, National Cancer Center Hospital East, Chiba, Japan.
  • Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Cross Cancer Institute, Alberta, Canada.
  • Department of Palliative and Supportive Medicine, Graduate School of Medicine, Aichi Medical University, Aichi, Japan.
  • Department of Medical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

ORCID-Profile: Koji Amano, Tomofumi Miura, Naoharu Mori, Yusuke Hiratsuka, Naosuke Yokomichi, Jun Hamano

Zitieren

APA

Amano, K., Okamura, S., Miura, T., Baracos, V. E., Mori, N., Sakaguchi, T., Uneno, Y., Ishiki, H., Hiratsuka, Y., Yokomichi, N., Hamano, J., Baba, M., Mori, M., & Morita, T. (2025). Clinical Implications of the C-Reactive Protein–Albumin Ratio as a Prognostic Marker in Terminally Ill Patients with Cancer. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2024.0471

Vancouver

Amano K, Okamura S, Miura T, Baracos VE, Mori N, Sakaguchi T, et al. Clinical Implications of the C-Reactive Protein–Albumin Ratio as a Prognostic Marker in Terminally Ill Patients with Cancer. Journal of Palliative Medicine. 2025. doi:10.1089/jpm.2024.0471

BibTeX
@article{Amano2025,
  author = {Amano, Koji and Okamura, Satomi and Miura, Tomofumi and Baracos, Vickie E and Mori, Naoharu and Sakaguchi, Tatsuma and Uneno, Yu and Ishiki, Hiroto and Hiratsuka, Yusuke and Yokomichi, Naosuke and Hamano, Jun and Baba, Mika and Mori, Masanori and Morita, Tatsuya},
  title = {Clinical Implications of the C-Reactive Protein–Albumin Ratio as a Prognostic Marker in Terminally Ill Patients with Cancer},
  journal = {Journal of Palliative Medicine},
  year = {2025},
  doi = {10.1089/jpm.2024.0471}
}
Kostenlos starten →